Drugmaker Novartis is taking legal action in Britain to make state-run hospitals use an eye drug that costs about $1,130 per shot instead of a cheaper one that costs $97.
Novartis takes legal action to push use of costlier eye drug
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.